Figure 5.
(A) Percentage of sub-G1 peaks in U937 cells after treatment with 2a–c, 4a–c and their respective references compounds 2 and 4, all tested at 1 µM for 24 and 48 h. (B) FACS panel relative to the sub-G1 peaks.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.